MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer

被引:45
作者
Wang, Chunyu [1 ,2 ]
Sun, Hongmiao [1 ,2 ]
Zou, Renlong [1 ,2 ]
Zhou, Tingting [1 ,2 ]
Wang, Shengli [1 ,2 ]
Sun, Shiying [1 ,2 ]
Tong, Changci [1 ,2 ]
Luo, Hao [1 ,2 ]
Li, Yanshu [1 ,2 ]
Li, Zhenhua [3 ]
Wang, Enhua [4 ]
Chen, Yuhua [1 ,2 ]
Cao, Liu [1 ,2 ]
Li, Feng [1 ,2 ]
Zhao, Yue [1 ,2 ]
机构
[1] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang 110122, Liaoning, Peoples R China
[2] China Med Univ, Key Lab Med Cell Biol, Minist Educ, Shenyang 110122, Liaoning, Peoples R China
[3] China Med Univ, Affiliated Hosp 1, Dept Urol, Shenyang 110001, Liaoning, Peoples R China
[4] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
DNA-DAMAGE CHECKPOINT; NUCLEAR RECEPTORS; TRANSCRIPTIONAL ACTIVITY; CHROMATIN RETENTION; BINDING PROTEIN; MRN COMPLEX; GROWTH; PROGRESSION; METASTASIS; ACTIVATION;
D O I
10.1093/nar/gkv394
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mediator of DNA damage checkpoint protein 1 (MDC1) is essential for DNA damage response. However, the role of MDC1 in modulating gene transcription independently of DNA damage and the underlying mechanisms have not been fully defined. Androgen receptor (AR) is the central signaling pathway in prostate cancer (PCa) and its target genes are involved in both promotion and suppression of PCa. Here, we functionally identified MDC1 as a coactivator of AR. We demonstrate that MDC1 facilitates the association between AR and histone acetyltransferase GCN5, thereby increasing histone H3 acetylation level on cis-regulatory elements of AR target genes. MDC1 knockdown promotes PCa cells growth and migration. Moreover, depletion of MDC1 results in decreased expression of a subset of the endogenous androgen-induced target genes, including cell cycle negative regulator p21 and PCa metastasis inhibitor Vinculin, in AR positive PCa cell lines. Finally, the expression of MDC1 and p21 correlates negatively with aggressive phenotype of clinical PCa. These studies suggest that MDC1 as an epigenetic modifier regulates AR transcriptional activity and MDC1 may function as a tumor suppressor of PCa, and provide new insight into co-factor-AR-signaling pathway mechanism and a better understanding of the function of MDC1 on PCa.
引用
收藏
页码:4893 / 4908
页数:16
相关论文
共 57 条
[1]   Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression [J].
Agoulnik, IU ;
Vaid, A ;
Bingman, WE ;
Erdeme, H ;
Frolov, A ;
Smith, CL ;
Ayala, G ;
Ittmann, MM ;
Weigel, NL .
CANCER RESEARCH, 2005, 65 (17) :7959-7967
[2]   Genomic Instability, Defective Spermatogenesis, Immunodeficiency, and Cancer in a Mouse Model of the RIDDLE Syndrome [J].
Bohgaki, Toshiyuki ;
Bohgaki, Miyuki ;
Cardoso, Renato ;
Panier, Stephanie ;
Zeegers, Dimphy ;
Li, Li ;
Stewart, Grant S. ;
Sanchez, Otto ;
Hande, M. Prakash ;
Durocher, Daniel ;
Hakem, Anne ;
Hakem, Razqallah .
PLOS GENETICS, 2011, 7 (04)
[3]   Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy [J].
Cao, Bo ;
Qi, Yanfeng ;
Zhang, Guanyi ;
Xu, Duo ;
Zhan, Yang ;
Alvarez, Xavier ;
Guo, Zhiyong ;
Fu, Xueqi ;
Plymate, Stephen R. ;
Sartor, Oliver ;
Zhang, Haitao ;
Dong, Yan .
ONCOTARGET, 2014, 5 (06) :1646-1656
[4]   Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage [J].
Chapman, J. Ross ;
Jackson, Stephen P. .
EMBO REPORTS, 2008, 9 (08) :795-801
[5]   A transcriptional repressor co-regulatory network governing androgen response in prostate cancers [J].
Chng, Kern Rei ;
Chang, Cheng Wei ;
Tan, Si Kee ;
Yang, Chong ;
Hong, Shu Zhen ;
Sng, Noel Yan Wei ;
Cheung, Edwin .
EMBO JOURNAL, 2012, 31 (12) :2810-2823
[6]   The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer [J].
Clark, Emma L. ;
Coulson, Anne ;
Dalgliesh, Caroline ;
Rajan, Prabhakar ;
Nicol, Samantha M. ;
Fleming, Stewart ;
Heer, Rakesh ;
Gaughan, Luke ;
Leung, Hing Y. ;
Elliott, David J. ;
Fuller-Pace, Frances V. ;
Robson, Craig N. .
CANCER RESEARCH, 2008, 68 (19) :7938-7946
[7]   TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth [J].
Daniels, Garrett ;
Li, Yirong ;
Gellert, Lan Lin ;
Zhou, Albert ;
Melamed, Jonathan ;
Wu, Xinyu ;
Zhang, Xinming ;
Zhang, David ;
Meruelo, Daniel ;
Logan, Susan K. ;
Basch, Ross ;
Lee, Peng .
ENDOCRINE-RELATED CANCER, 2014, 21 (01) :127-142
[8]   Recognition of Double Strand Breaks by a Mutator Protein (MU2) in Drosophila melanogaster [J].
Dronamraju, Raghuvar ;
Mason, James M. .
PLOS GENETICS, 2009, 5 (05)
[9]   The development of androgen-independent prostate cancer [J].
Feldman, BJ ;
Feldman, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :34-45
[10]   p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation [J].
Fu, MF ;
Wang, CG ;
Reutens, AT ;
Wang, J ;
Angeletti, RH ;
Siconolfi-Baez, L ;
Ogryzko, V ;
Avantaggiati, ML ;
Pestell, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (27) :20853-20860